GLASF
Price
$6.48
Change
-$0.03 (-0.46%)
Updated
Sep 26 closing price
Capitalization
503.33M
SWGHF
Price
$11.52
Change
-$1.88 (-14.03%)
Updated
Apr 7 closing price
Capitalization
1.6B
Interact to see
Advertisement

GLASF vs SWGHF

Header iconGLASF vs SWGHF Comparison
Open Charts GLASF vs SWGHFBanner chart's image
Glass House Brands
Price$6.48
Change-$0.03 (-0.46%)
Volume$88.56K
Capitalization503.33M
SAWAI GROUP
Price$11.52
Change-$1.88 (-14.03%)
Volume$120
Capitalization1.6B
GLASF vs SWGHF Comparison Chart in %
Loading...
GLASF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLASF vs. SWGHF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLASF is a Hold and SWGHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (GLASF: $6.48 vs. SWGHF: $11.52)
Brand notoriety: GLASF and SWGHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GLASF: 42% vs. SWGHF: 100%
Market capitalization -- GLASF: $503.33M vs. SWGHF: $1.6B
GLASF [@Pharmaceuticals: Generic] is valued at $503.33M. SWGHF’s [@Pharmaceuticals: Generic] market capitalization is $1.6B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLASF’s FA Score shows that 0 FA rating(s) are green whileSWGHF’s FA Score has 1 green FA rating(s).

  • GLASF’s FA Score: 0 green, 5 red.
  • SWGHF’s FA Score: 1 green, 4 red.
According to our system of comparison, SWGHF is a better buy in the long-term than GLASF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLASF’s TA Score shows that 4 TA indicator(s) are bullish.

  • GLASF’s TA Score: 4 bullish, 5 bearish.

Price Growth

GLASF (@Pharmaceuticals: Generic) experienced а -6.36% price change this week, while SWGHF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SWGHF($1.6B) has a higher market cap than GLASF($503M). GLASF has higher P/E ratio than SWGHF: GLASF (513.07) vs SWGHF (15.65). GLASF YTD gains are higher at: 11.724 vs. SWGHF (-14.030). SWGHF has higher annual earnings (EBITDA): 36B vs. GLASF (49M). SWGHF has more cash in the bank: 51.4B vs. GLASF (40.7M). GLASF has less debt than SWGHF: GLASF (72.8M) vs SWGHF (93.4B). SWGHF has higher revenues than GLASF: SWGHF (177B) vs GLASF (222M).
GLASFSWGHFGLASF / SWGHF
Capitalization503M1.6B31%
EBITDA49M36B0%
Gain YTD11.724-14.030-84%
P/E Ratio513.0715.653,278%
Revenue222M177B0%
Total Cash40.7M51.4B0%
Total Debt72.8M93.4B0%
FUNDAMENTALS RATINGS
GLASF vs SWGHF: Fundamental Ratings
GLASF
SWGHF
OUTLOOK RATING
1..100
7339
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9598
PRICE GROWTH RATING
1..100
6075
P/E GROWTH RATING
1..100
10084
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SWGHF's Valuation (11) in the null industry is significantly better than the same rating for GLASF (94). This means that SWGHF’s stock grew significantly faster than GLASF’s over the last 12 months.

SWGHF's Profit vs Risk Rating (100) in the null industry is in the same range as GLASF (100). This means that SWGHF’s stock grew similarly to GLASF’s over the last 12 months.

GLASF's SMR Rating (95) in the null industry is in the same range as SWGHF (98). This means that GLASF’s stock grew similarly to SWGHF’s over the last 12 months.

GLASF's Price Growth Rating (60) in the null industry is in the same range as SWGHF (75). This means that GLASF’s stock grew similarly to SWGHF’s over the last 12 months.

SWGHF's P/E Growth Rating (84) in the null industry is in the same range as GLASF (100). This means that SWGHF’s stock grew similarly to GLASF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLASFSWGHF
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
7%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
8%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GLASF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEVDX12.820.17
+1.34%
Driehaus Event Driven
VGHAX75.100.72
+0.97%
Vanguard Health Care Adm
AALRX29.220.28
+0.97%
American Beacon Large Cap Value R6
CIOVX19.440.01
+0.05%
Causeway International Opps Inv
MLPOX9.06N/A
N/A
Invesco SteelPath MLP Alpha Y

GLASF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLASF
1D Price
Change %
GLASF100%
-0.46%
TSNDF - GLASF
62%
Loosely correlated
-2.69%
GTBIF - GLASF
62%
Loosely correlated
-2.02%
TCNNF - GLASF
58%
Loosely correlated
+1.09%
VRNOF - GLASF
58%
Loosely correlated
-1.72%
CRLBF - GLASF
57%
Loosely correlated
-1.90%
More

SWGHF and

Correlation & Price change

A.I.dvisor tells us that SWGHF and MEDIF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SWGHF and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SWGHF
1D Price
Change %
SWGHF100%
N/A
MEDIF - SWGHF
29%
Poorly correlated
-2.58%
DERM - SWGHF
25%
Poorly correlated
+2.32%
STEK - SWGHF
21%
Poorly correlated
+18.32%
AAWH - SWGHF
16%
Poorly correlated
-3.12%
GLASF - SWGHF
4%
Poorly correlated
-0.46%
More